02-Mar-2021

Recombinant Vaccines Market Witnessing Four Fold Growth in 2019 Growing at CAGR of over 6.0% – Forecast to 2025

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Increasing awareness regarding prevention of vaccine preventable lethal diseases is expected to propel growth of the global recombinant vaccines market over the forecast period. Vaccination offers effective protection from various diseases caused by bacteria and viruses such as influenza, cholera, mumps, and human papilloma virus. According to Children’s Hospital of Philadelphia report 2014, there were around 85% of children over the globe vaccinated to protect them against tuberculosis, polio, diphtheria, tetanus, pertussis, and measles and these vaccines. Moreover, recombinant vaccines offer no side effects. Moreover, increasing prevalence influenza is also expected to boost growth of the market. For instance, according to the Centers of Disease Control and Prevention, the U.S. recorded around 29 million influenza cases in the 2019-2020 season.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/455

Increasing prevalence of zoonotic diseases such as swine flu, malaria, and HPV is also boosting growth of the global recombinant vaccines market. Vaccination has also led to eradication of diseases such as polio and tetanus in few countries. In 2015, there were around 212 million cases of malaria in the U.S. and 429,000 deaths were reported due to the disease. Moreover, according to the Centers for Disease Control and Prevention, 2017, in the U.S., around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine.

Increasing cases of vaccine-preventable diseases are expected to fuel growth of the global recombinant vaccines market over the forecast period. For instance, according to Children’s Hospital of Philadelphia’s report in 2014, around 3 million people die from vaccine-preventable diseases, annually, worldwide and around 1.5 million of these deaths are reported among children less than 5 years of age due to several infectious diseases.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/455

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in February 2020, Novavax, Inc., a late-stage biotechnology company, announced that it has produced and is currently assessing multiple nanoparticle vaccine candidates for COVID-19 in animal models prior to identifying an optimal candidate for human testing, which is expected to begin by the end of spring 2020.

Key Takeaways

The global recombinant vaccines market was valued at US$ 830.2 million in 2016 and is projected to witness a CAGR of 6.0% during the forecast period (2017–2025)
Increasing awareness on prevention of vaccine-preventable diseases is expected to propel growth of the global recombinant vaccines market over the forecast period
Increasing R&D of effective vaccines for the treatment of diseases such as zika virus, cancer, and others is also contributing to growth of the market
The reprocessed medical devices is expected to expand at a CAGR of 6.0% during the forecast period (2017–2025)
Infectious disease segment was valued at US$ 556.6 Mn in 2016 and is expected to reach US$ 972.3 Mn by 2025 at a CAGR of 6.5% over the forecast period
North America is expected to witness high growth in the global recombinant vaccines market over the forecast period, owing to increasing prevalence of cancer. For instance, According to the Centers of Disease Control and Prevention’s U.S. Cancer Statistics September 2019, around 94,000 women were diagnosed with gynecologic cancer each year, in the U.S., between 2012 and 2016.
Major players operating in the global recombinant vaccines market include Merck &Co. Inc., Green Cross Corporation, Pfizer Inc., Bayer AG, Sanofi S A., Protein Science Corporation, GlaxoSmithKline Plc., Novartis AG, and Bharat Biotech

To know the latest trends and insights prevalent in the Global Recombinant Vaccines Market press release, click the link below: https://www.coherentmarketinsights.com/press-release/recombinant-vaccines-market-to-surpass-us-13-bn-threshold-by-2025-with-north-america-positioned-as-growth-engine-334

Table of Contents

Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet By Product Type
  - Market Snippet By Disease Type
  - Market Snippet By End User
  - Market Snippet By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Regulatory Scenario
- Industry Trend
- Epidemiology/Prevalence/Incidence
- Merger and Acquisitions
- New Product Type Approvals/Launch
- Promotion and Marketing Initiatives
Global Recombinant Vaccines Market, By Product Type, 2015 – 2025 (USD Million)
- Introduction
  - Market Share Analysis, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, 2015 – 2025
  - Segment Trends
- Subunit Recombinant Vaccines
- Attenuated Recombinant Vaccines
- Vector Recombinant Vaccines
Global Recombinant Vaccines Market, By Disease Type, 2015 – 2025 (USD Million)
- Introduction
  - Market Share Analysis, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, 2015 – 2025
  - Segment Trends
- Infectious Disease
- Cancer
- Allergy
- Others
Global Recombinant Vaccines Market, By End User, 2015 – 2025 (USD Million)
- Introduction
  - Market Share Analysis, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, 2015 – 2025
  - Segment Trends
- Recombinant Human Vaccines
- Animal Recombinant Vaccines
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
    - Poultry
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
    - Companion Animal Vaccines
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
    - Livestock
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
    - Porcine
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
    - Aquaculture Vaccines
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2015 – 2025, (USD Million)
Global Recombinant Vaccines Market, By Regions, 2015 – 2025 (USD Million)
- Introduction
  - Market Share Analysis, By Region, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, For Regions, 2015 – 2025
- North America
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - U.S.
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Canada
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
- Europe
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - U.K.
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Germany
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Italy
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - France
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Russia
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Others
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
- Asia Pacific
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - China
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - India
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Japan
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - ASEAN
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Australia
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - South Korea
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Others
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
- Latin America
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - Brazil
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Mexico
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Others
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
- Africa
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - Northern Africa
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Central Africa
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - South Africa
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
- Middle East
  - Market Share Analysis, By Country, 2016 and 2025 (%)
  - Y-O-Y Growth Analysis, By Country, 2015 – 2025
    - GCC Countries
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
    - Israel
      - Country Trends
      - Market Size and Forecast, By Product Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By Disease Type, 2015 – 2025 (USD Million)
      - Market Size and Forecast, By End User, 2015 – 2025 (USD Million)
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3×3 Matrix)
- Company Profiles
  - Merck & Co., Inc.
    - Company Overview
    - Product Type Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Future Plans
  - Green Cross Corporation
  - Pfizer, Inc.
  - Sanofi S A.
  - Protein Science Corporation
  - GlaxoSmithKline Plc
  - Novartis AG
  - Bharat Biotech
Section
- References
- Research Methodology
- About us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 02-Mar-2021